Gabrielle Campbell

5.0k total citations · 4 hit papers
81 papers, 3.3k citations indexed

About

Gabrielle Campbell is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Anesthesiology and Pain Medicine. According to data from OpenAlex, Gabrielle Campbell has authored 81 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Public Health, Environmental and Occupational Health, 35 papers in Pharmacology and 24 papers in Anesthesiology and Pain Medicine. Recurrent topics in Gabrielle Campbell's work include Opioid Use Disorder Treatment (44 papers), Pain Management and Opioid Use (24 papers) and Musculoskeletal pain and rehabilitation (18 papers). Gabrielle Campbell is often cited by papers focused on Opioid Use Disorder Treatment (44 papers), Pain Management and Opioid Use (24 papers) and Musculoskeletal pain and rehabilitation (18 papers). Gabrielle Campbell collaborates with scholars based in Australia, United Kingdom and United States. Gabrielle Campbell's co-authors include Louisa Degenhardt, Wayne Hall, Suzanne Nielsen, Michael Farrell, Raimondo Bruno, Nicholas Lintzeris, Briony Larance, Milton Cohen, Emily Stockings and Dino Zagic and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Gabrielle Campbell

77 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence

2021 323 citations Thomas Santo, Gabrielle Campbell et al. profile →
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis

2019 296 citations Emily Stockings, Gabrielle Campbell et al. profile →
Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies

2018 293 citations Emily Stockings, Gabrielle Campbell et al. Pain profile →
Public health implications of legalising the production and sale of cannabis for medicinal and recreational use

2019 232 citations Wayne Hall, Janni Leung et al. profile →

Peers

Gabrielle Campbell

PHARM

PHEOH

EPIDE

PPCH

APM

Linda Gowing Australia

Maria A. Sullivan United States

Suzanne Nielsen Australia

Nicholas Lintzeris Australia

Laura Amato Italy

Kelly E. Dunn United States

Maureen Hillhouse United States

Michelle R. Lofwall United States

Adrian Dunlop Australia

Evgeny Krupitsky Russia

Linda Gowing Australia

Gabrielle Campbell

822 ×0.5

PHARM

1.3k ×1.0

PHEOH

1.5k ×1.5

EPIDE

475 ×0.8

PPCH

262 ×0.5

APM

Citations per year, relative to Gabrielle Campbell Gabrielle Campbell (= 1×) peers Linda Gowing

Countries citing papers authored by Gabrielle Campbell

Since Specialization

Citations

This map shows the geographic impact of Gabrielle Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabrielle Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabrielle Campbell more than expected).

Fields of papers citing papers by Gabrielle Campbell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabrielle Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabrielle Campbell. The network helps show where Gabrielle Campbell may publish in the future.

Co-authorship network of co-authors of Gabrielle Campbell

This figure shows the co-authorship network connecting the top 25 collaborators of Gabrielle Campbell. A scholar is included among the top collaborators of Gabrielle Campbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabrielle Campbell. Gabrielle Campbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kerr, Jessica A., Janni Leung, S. Ghazaleh Dashti, et al.. (2025). The natural history of DSM-5 alcohol-use disorder from late adolescence to middle adulthood in Australia: a prospective cohort study. The Lancet Public Health. 10(11). e923–e932.

Santo, Thomas, Gabrielle Campbell, Samantha Colledge‐Frisby, et al.. (2024). Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis. International Journal of Drug Policy. 128. 104434–104434. 5 indexed citations

Campbell, Gabrielle & Briony Larance. (2024). Commentary on Yang et al.: The need for a renewed focus on identifying and responding to chronic pain among people with substance use disorders. Addiction. 119(11). 1902–1903.

Leung, Janni, Lauren A. Gardner, Gabrielle Campbell, et al.. (2024). The Use and Knowledge Around Vaping and Their Correlates Among University Students—A Cross-sectional Australian Study. International Journal of Mental Health and Addiction. 23(4). 3105–3121.

Meredith, Pamela, Ann Kennedy‐Behr, Gabrielle Campbell, et al.. (2023). Picky eating in children: Current clinical trends, practices, and observations within the Australian health‐care context. Australian Occupational Therapy Journal. 70(4). 471–486. 6 indexed citations

Campbell, Gabrielle, Louisa Degenhardt, Nicholas Lintzeris, et al.. (2022). Self-reported challenges obtaining ongoing prescription opioids among Australians with chronic non-cancer pain. International Journal of Drug Policy. 105. 103708–103708. 5 indexed citations

Darke, Shane, et al.. (2021). Barbiturate‐related hospitalisations, drug treatment episodes, and deaths in Australia, 2000‒2018. The Medical Journal of Australia. 216(4). 194–198. 3 indexed citations

Santo, Thomas, Gabrielle Campbell, Natasa Gisev, & Louisa Degenhardt. (2021). Exposure to childhood trauma increases risk of opioid use disorder among people prescribed opioids for chronic non-cancer pain. Drug and Alcohol Dependence. 230. 109199–109199. 14 indexed citations

Campbell, Gabrielle, et al.. (2020). Trends and characteristics in barbiturate deaths Australia 2000–2019: a national retrospective study. Clinical Toxicology. 59(3). 224–230. 4 indexed citations

10.

Campbell, Gabrielle, Emily Stockings, & Suzanne Nielsen. (2019). Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain. European Archives of Psychiatry and Clinical Neuroscience. 269(1). 135–144. 28 indexed citations

11.

Shanahan, Marian, et al.. (2019). A protocol for a discrete choice experiment: understanding patient medicine preferences for managing chronic non-cancer pain. BMJ Open. 9(8). e027153–e027153. 14 indexed citations

12.

Stockings, Emily, Gabrielle Campbell, Wayne Hall, et al.. (2018). Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies. Pain. 159(10). 1932–1954. 293 indexed citations breakdown →

13.

Stockings, Emily, Gabrielle Campbell, Wayne Hall, et al.. (2018). CANNABINOIDS FOR THE TREATMENT OF CHRONIC NON-CANCER PAIN: AN OVERVIEW OF THE EVIDENCE. Drug and Alcohol Review. 37. 1 indexed citations

14.

Peacock, Amy, Louisa Degenhardt, Gabrielle Campbell, et al.. (2016). A Typology of Predictive Risk Factors for Non-Adherent Medication-Related Behaviors among Chronic Non-Cancer Pain Patients Prescribed Opioids: A Cohort Study.. PubMed. 19(3). E421–34. 1 indexed citations

15.

Nielsen, Suzanne, Gabrielle Campbell, Amy Peacock, et al.. (2015). Health service utilisation by people living with chronic non-cancer pain: findings from the Pain and Opioids IN Treatment (POINT) study. Australian Health Review. 40(5). 490–499. 12 indexed citations

16.

Mattick, Richard P., Raimondo Bruno, Suzanne Nielsen, et al.. (2015). Factors associated with the development of depression in chronic non-cancer pain patients following the onset of opioid treatment for pain. Journal of Affective Disorders. 184. 72–80. 26 indexed citations

17.

Campbell, Gabrielle, Raimondo Bruno, Shane Darke, et al.. (2015). Prevalence and Correlates of Suicidal Thoughts and Suicide Attempts in People Prescribed Pharmaceutical Opioids for Chronic Pain. Clinical Journal of Pain. 32(4). 292–301. 36 indexed citations

18.

Nielsen, Suzanne, Nicholas Lintzeris, Raimondo Bruno, et al.. (2014). Benzodiazepine Use among Chronic Pain Patients Prescribed Opioids: Associations with Pain, Physical and Mental Health, and Health Service Utilization. Pain Medicine. 16(2). 356–366. 92 indexed citations

19.

Darke, Shane, et al.. (2011). Retention, early dropout and treatment completion among therapeutic community admissions. Drug and Alcohol Review. 31(1). 64–71. 78 indexed citations

20.

Kinner, Stuart A., Jessica George, Gabrielle Campbell, & Louisa Degenhardt. (2009). Crime, drugs and distress: patterns of drug use and harm among criminally involved injecting drug users in Australia. Australian and New Zealand Journal of Public Health. 33(3). 223–227. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact